optimising oral peptide delivery innovative strategies are essential to enhance peptide stability, retention, and permeation - Barriers and strategies fororal peptideand protein therapeuticsdelivery peptide Optimising Oral Peptide Delivery: Navigating Challenges for Enhanced Bioavailability

Oralpeptides The quest for effective oral peptide delivery is a significant frontier in pharmaceutical development, promising to revolutionize how peptides are administered and improving patient convenienceBioMed X and Novo Nordisk Launch New Collaboration in .... Historically, the oral route for peptide therapeutics has been plagued by numerous challenges, primarily stemming from the harsh gastrointestinal environment and the inherent properties of peptides themselves. However, optimising oral peptide delivery is becoming increasingly achievable through a combination of innovative strategies and a deeper understanding of the underlying biological and chemical hurdles.

One of the primary obstacles is the degradation of peptides by enzymes in the digestive tract and the acidic pH of the stomach. A suitable oral delivery system must therefore be designed to maintain its integrity until it reaches the intended site of absorptionDosage Form Optimization Case Study Preceding Clinical .... This necessitates careful optimization of the formulation to protect the peptide from enzymatic breakdown and harsh chemical conditions. Researchers are exploring various approaches, including the development of self-emulsifying drug delivery systems (SEDDS), which can encapsulate peptides and shield them from degradation.2022年1月1日—Oral deliveryis a promising alternative but hindered by harsh gastrointestinal environment and defensive intestinal epithelial barriers. The study by Postina et al2025年8月10日—A suitable oral delivery system should retain the drug andmaintain its integrityuntil it gets to the region of maximum absorption where the .... (2025) highlights an emerging approach using SEDDS designed for effective oral peptide drug delivery, capable of protecting the peptide cargoThe promising future of GLP-1s and oral peptides.

Beyond enzymatic degradation, peptides face significant challenges in crossing the intestinal epithelial barrier2024年5月30日—This review covers the need forpeptide deliveryvia theoralroute and offers insights to overcome the challenges. For successful translation .... The relatively large size and hydrophilic nature of peptides make passive diffusion across this barrier inefficient. To overcome this, researchers are focusing on strategies to significantly improve the absorption and bioavailability of peptide-based therapeutics. This involves enhancing peptide stability, retention, and permeation within the oral cavity and gastrointestinal tract. Oral peptide delivery faces stability and permeability challenges, which are being addressed through advanced formulation techniques.作者：MA Karsdal·2008·被引用次数：85—Optimizing bioavailability of oral administration of small peptidesthrough pharmacokinetic and pharmacodynamic parameters: The effect of ...

Several approaches are being employed to tackle these permeability issues.作者：H Tran·2022·被引用次数：27—This review summarizes key learnings from the use of permeation enhancers (PEs) fororal peptide deliveryassociated with solid dosage formoptimization. Permeation enhancers (PEs) are a key area of research, as highlighted by Tran et al. (2022), who summarized learnings from their use in solid dosage form optimizationRecent Progress in the Oral Delivery of Therapeutic .... These enhancers can temporarily increase the permeability of the intestinal lining, allowing peptides to pass through more readily. Furthermore, lipid and polymer-based carriers are proving to be effective in enhancing peptide absorption, as noted by Al Tahan et al. (2025). These carriers can protect the peptide and facilitate its transport across the intestinal epithelium.

Another promising avenue for optimising oral peptide delivery involves chemical modifications and the use of advanced delivery systems. Prodrug strategies, for instance, involve chemically altering the peptide to improve its oral absorption, with the active peptide being released in the body.Recent studies demonstrate thatoptimizing SEDDS with specific excipients(e.g., caprylic acid and PEG-35 castor oil) can inhibit aminopeptidase ... The concept of improving oral bioavailability of peptides through chemical alteration of amino acids is a significant area of investigation, as discussed in a 2025 publication. Additionally, peptide cyclization can potentially enhance oral bioavailability by reducing the exposure of polar atoms and altering peptide conformations into more bioactive forms, as suggested by Nicze et al. (2024).

The delivery of therapeutic peptides via the oral route is a complex undertaking that requires a multifaceted approachMechanistic Insights for Translation to Clinic. Researchers are actively investigating novel enabling strategies for oral peptide delivery to transform the therapeutic landscape of peptide-based medicines. The development of effective oral peptide delivery systems is crucial for realizing the full potential of these powerful therapeutic agentsStrategies to improve oral peptide delivery system .... By focusing on optimising SEDDS with specific excipients, such as caprylic acid and PEG-35 castor oil, to inhibit enzymes like aminopeptidase, and by altering the formulation for maximum solubility, scientists are making significant stridesOptimising oral systems for the delivery of therapeutic proteins ....

The ultimate goal is to achieve a level of oral bioavailability comparable to or exceeding that of parenteral administration, thereby offering a more convenient and patient-friendly optionBioMed X and Novo Nordisk Launch New Collaboration in .... This involves not only protecting the peptide but also ensuring its effective release and absorption at the desired site. As research progresses, the development of Delivery systems that can reliably transport peptides across biological barriers and into systemic circulation will pave the way for a new era of oral peptide therapeutics.This publication has 28 references indexed in Scilit: Improvement oforal peptidebioavailability: Peptidomimetics and prodrug strategies. The ongoing efforts in peptide delivery research are critical for overcoming the inherent limitations of the oral route and unlocking its therapeutic promise.Formulation strategies to improve oral peptide delivery The ultimate success in optimising bioavailability of oral administration of small peptides will depend on a comprehensive understanding of pharmacokinetic and pharmacodynamic parameters, alongside innovative formulation design.作者：KC Baral·2025·被引用次数：45—This review presentsoralPPs as a promising platform, highlighting the key barriers and strategies to transform their therapeutic landscapes.